|
|
|
Volumn 62, Issue RR09, 2013, Pages 1-12
|
|
Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEDAQUILINE;
QUINOLINE DERIVATIVE;
TUBERCULOSTATIC AGENT;
ADOLESCENT;
ADULT;
AGED;
CHILD;
DRUG MONITORING;
FEMALE;
HUMAN;
LITERATURE;
MIDDLE AGED;
OFF LABEL DRUG USE;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRACTICE GUIDELINE;
PREGNANCY;
PUBLIC HEALTH SERVICE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
STANDARDS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
UNITED STATES;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
ANTITUBERCULAR AGENTS;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
CHILD;
CLINICAL TRIALS, PHASE II AS TOPIC;
DIARYLQUINOLINES;
DRUG MONITORING;
FEMALE;
HUMANS;
MIDDLE AGED;
OFF-LABEL USE;
PREGNANCY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REVIEW LITERATURE AS TOPIC;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
UNITED STATES;
YOUNG ADULT;
|
|
EID: 84891539408
PISSN: None
EISSN: 15458601
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (74)
|
|
References (0)
|